mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |